Request Case Review
Zhongshan Hospital复旦大学附属中山医院
Official portrait of Ge Junbo shown in a Fudan University Institute of Biomedical Sciences profile page.
Department of Cardiology

Ge Junbo

葛均波

Academician of the Chinese Academy of Sciences, Chief Physician, Professor, Doctoral Supervisor, and Director of Cardiology

Zhongshan Hospital复旦大学附属中山医院· Shanghai

Areas of Expertise

Interventional cardiology for coronary artery diseaseComplex coronary interventionChronic total occlusionIntravascular ultrasound-guided diagnosis and therapyMyocardial bridgingCoronary device innovation
Request Consultation with Junbo

Professional Biography

Dr. Ge Junbo is Academician of the Chinese Academy of Sciences, Chief Physician, Professor, Doctoral Supervisor, and Director of Cardiology at Zhongshan Hospital, Shanghai. Junbo specializes in Interventional cardiology for coronary artery disease, especially complex coronary intervention, chronic total occlusion, intravascular ultrasound-guided diagnosis and therapy, myocardial bridging, and coronary device innovation.

Education & Training

  • Qingdao Medical College (1984)
  • MD / Doctor of Medicine, University of Mainz Faculty of Medicine
  • University of Mainz Faculty of Medicine — Cardiology advanced study and doctoral training (Germany)

Notable Publications

Prognostic Value of Angiographic Microcirculatory Resistance After Coronary Intervention: Insights From the FAVOR III China Trial.

Journal of the American Heart Association (2026) — co-author

PubMed/DOI

Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease.

International Journal of Cardiology (2019) — corresponding author

PubMed/DOI

Leadership & Positions

  • Director, Department of Cardiology, Zhongshan Hospital, Fudan University
  • Director, Cardiac Catheterization Laboratory, Zhongshan Hospital, Fudan University
  • Director, Shanghai Institute of Cardiovascular Diseases

Pioneering Contributions

1

Identified the intravascular ultrasound 'half-moon sign' in myocardial bridging, materially improving recognition and management of this lesion.

2

Introduced and advanced complex coronary intervention strategies in China, including the retrograde guidewire technique for chronic total occlusion, which later became a standard CTO crossing method internationally.

3

Led development of China's first biodegradable-polymer drug-eluting coronary stent and the fully bioresorbable XINSORB scaffold platform, linking interventional practice with domestic device innovation.

International Patient Services

Full support for your journey to China

Medipath provides comprehensive support for international patients. Services include full English-speaking medical consultations, dedicated medical translation staff, and specialized assistance with medical visa applications to ensure a seamless healthcare journey.

English Consultations

Full English-speaking medical appointments

Medical Translation

Dedicated translation for all documentation

Visa Assistance

Medical visa application support